| Dr Allan R Kornfeld, MD | |
|
2400 N Rockton Ave, Rockford, IL 61103-3655 | |
| (815) 971-2000 | |
| Not Available |
| Full Name | Dr Allan R Kornfeld |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 35 Years |
| Location | 2400 N Rockton Ave, Rockford, Illinois |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134278831 | NPI | - | NPPES |
| 036092593 | Medicaid | IL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 036-092593 (Illinois) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Saint James Hospital | Pontiac, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Osf Multi-specialty Group | 3678889789 | 1543 |
News Archive
Simcere Pharmaceutical Group, a leading manufacturer and supplier of branded generic pharmaceuticals and manufacturer of the patented anti-cancer biotech product Endostar (also known as Endu) in China, announced today the successful completion of Endostar Phase IV clinical study at a conference in Beijing dedicated to this study.
Merck KGaA announced today that it has acquired Suzhou Taizhu Technology Development Co. Ltd. ("Taizhu"), a leading supplier of effect pigments located in Taicang near Shanghai, China. With total revenues of more than € 14 million in 2008 and 300 employees Taizhu is one of the biggest effect pigments companies in the Chinese market. The acquisition is of high strategic importance to the Merck pigments business.
Neurobiological Technologies, Inc. (Nasdaq: NTII) ("NTI") announced today that, on September 15, 2009, it received a letter from The Nasdaq Stock Market indicating that the bid price of NTI's common stock has closed below $1.00 per share for 30 consecutive business days.
Researchers in the United States and Germany have conducted a study demonstrating the preclinical efficacy of a new candidate vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the agent that causes coronavirus disease 2019 (COVID-19).
A study co-authored by Dr. Michael A. Lindsey, Executive Director of the McSilver Institute for Poverty Policy & Research at the Silver of Social Work at New York University, has found that transgender people who are denied access to mental health treatment experience a higher risk of substance abuse and attempted suicide.
› Verified 9 days ago
| Entity Name | Rockford Health Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043242886 PECOS PAC ID: 2567374036 Enrollment ID: O20031103000584 |
News Archive
Simcere Pharmaceutical Group, a leading manufacturer and supplier of branded generic pharmaceuticals and manufacturer of the patented anti-cancer biotech product Endostar (also known as Endu) in China, announced today the successful completion of Endostar Phase IV clinical study at a conference in Beijing dedicated to this study.
Merck KGaA announced today that it has acquired Suzhou Taizhu Technology Development Co. Ltd. ("Taizhu"), a leading supplier of effect pigments located in Taicang near Shanghai, China. With total revenues of more than € 14 million in 2008 and 300 employees Taizhu is one of the biggest effect pigments companies in the Chinese market. The acquisition is of high strategic importance to the Merck pigments business.
Neurobiological Technologies, Inc. (Nasdaq: NTII) ("NTI") announced today that, on September 15, 2009, it received a letter from The Nasdaq Stock Market indicating that the bid price of NTI's common stock has closed below $1.00 per share for 30 consecutive business days.
Researchers in the United States and Germany have conducted a study demonstrating the preclinical efficacy of a new candidate vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the agent that causes coronavirus disease 2019 (COVID-19).
A study co-authored by Dr. Michael A. Lindsey, Executive Director of the McSilver Institute for Poverty Policy & Research at the Silver of Social Work at New York University, has found that transgender people who are denied access to mental health treatment experience a higher risk of substance abuse and attempted suicide.
› Verified 9 days ago
| Entity Name | Rockford Anesthesiologists Associated Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639128598 PECOS PAC ID: 5597668004 Enrollment ID: O20040131000052 |
News Archive
Simcere Pharmaceutical Group, a leading manufacturer and supplier of branded generic pharmaceuticals and manufacturer of the patented anti-cancer biotech product Endostar (also known as Endu) in China, announced today the successful completion of Endostar Phase IV clinical study at a conference in Beijing dedicated to this study.
Merck KGaA announced today that it has acquired Suzhou Taizhu Technology Development Co. Ltd. ("Taizhu"), a leading supplier of effect pigments located in Taicang near Shanghai, China. With total revenues of more than € 14 million in 2008 and 300 employees Taizhu is one of the biggest effect pigments companies in the Chinese market. The acquisition is of high strategic importance to the Merck pigments business.
Neurobiological Technologies, Inc. (Nasdaq: NTII) ("NTI") announced today that, on September 15, 2009, it received a letter from The Nasdaq Stock Market indicating that the bid price of NTI's common stock has closed below $1.00 per share for 30 consecutive business days.
Researchers in the United States and Germany have conducted a study demonstrating the preclinical efficacy of a new candidate vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the agent that causes coronavirus disease 2019 (COVID-19).
A study co-authored by Dr. Michael A. Lindsey, Executive Director of the McSilver Institute for Poverty Policy & Research at the Silver of Social Work at New York University, has found that transgender people who are denied access to mental health treatment experience a higher risk of substance abuse and attempted suicide.
› Verified 9 days ago
| Entity Name | Saint James Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790735421 PECOS PAC ID: 0648187252 Enrollment ID: O20040804001073 |
News Archive
Simcere Pharmaceutical Group, a leading manufacturer and supplier of branded generic pharmaceuticals and manufacturer of the patented anti-cancer biotech product Endostar (also known as Endu) in China, announced today the successful completion of Endostar Phase IV clinical study at a conference in Beijing dedicated to this study.
Merck KGaA announced today that it has acquired Suzhou Taizhu Technology Development Co. Ltd. ("Taizhu"), a leading supplier of effect pigments located in Taicang near Shanghai, China. With total revenues of more than € 14 million in 2008 and 300 employees Taizhu is one of the biggest effect pigments companies in the Chinese market. The acquisition is of high strategic importance to the Merck pigments business.
Neurobiological Technologies, Inc. (Nasdaq: NTII) ("NTI") announced today that, on September 15, 2009, it received a letter from The Nasdaq Stock Market indicating that the bid price of NTI's common stock has closed below $1.00 per share for 30 consecutive business days.
Researchers in the United States and Germany have conducted a study demonstrating the preclinical efficacy of a new candidate vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the agent that causes coronavirus disease 2019 (COVID-19).
A study co-authored by Dr. Michael A. Lindsey, Executive Director of the McSilver Institute for Poverty Policy & Research at the Silver of Social Work at New York University, has found that transgender people who are denied access to mental health treatment experience a higher risk of substance abuse and attempted suicide.
› Verified 9 days ago
| Entity Name | North American Partners In Anesthesia Illinois Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699032524 PECOS PAC ID: 1052576519 Enrollment ID: O20120706000534 |
News Archive
Simcere Pharmaceutical Group, a leading manufacturer and supplier of branded generic pharmaceuticals and manufacturer of the patented anti-cancer biotech product Endostar (also known as Endu) in China, announced today the successful completion of Endostar Phase IV clinical study at a conference in Beijing dedicated to this study.
Merck KGaA announced today that it has acquired Suzhou Taizhu Technology Development Co. Ltd. ("Taizhu"), a leading supplier of effect pigments located in Taicang near Shanghai, China. With total revenues of more than € 14 million in 2008 and 300 employees Taizhu is one of the biggest effect pigments companies in the Chinese market. The acquisition is of high strategic importance to the Merck pigments business.
Neurobiological Technologies, Inc. (Nasdaq: NTII) ("NTI") announced today that, on September 15, 2009, it received a letter from The Nasdaq Stock Market indicating that the bid price of NTI's common stock has closed below $1.00 per share for 30 consecutive business days.
Researchers in the United States and Germany have conducted a study demonstrating the preclinical efficacy of a new candidate vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the agent that causes coronavirus disease 2019 (COVID-19).
A study co-authored by Dr. Michael A. Lindsey, Executive Director of the McSilver Institute for Poverty Policy & Research at the Silver of Social Work at New York University, has found that transgender people who are denied access to mental health treatment experience a higher risk of substance abuse and attempted suicide.
› Verified 9 days ago
| Entity Name | Osf Multi-specialty Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922445527 PECOS PAC ID: 3678889789 Enrollment ID: O20150904000279 |
News Archive
Simcere Pharmaceutical Group, a leading manufacturer and supplier of branded generic pharmaceuticals and manufacturer of the patented anti-cancer biotech product Endostar (also known as Endu) in China, announced today the successful completion of Endostar Phase IV clinical study at a conference in Beijing dedicated to this study.
Merck KGaA announced today that it has acquired Suzhou Taizhu Technology Development Co. Ltd. ("Taizhu"), a leading supplier of effect pigments located in Taicang near Shanghai, China. With total revenues of more than € 14 million in 2008 and 300 employees Taizhu is one of the biggest effect pigments companies in the Chinese market. The acquisition is of high strategic importance to the Merck pigments business.
Neurobiological Technologies, Inc. (Nasdaq: NTII) ("NTI") announced today that, on September 15, 2009, it received a letter from The Nasdaq Stock Market indicating that the bid price of NTI's common stock has closed below $1.00 per share for 30 consecutive business days.
Researchers in the United States and Germany have conducted a study demonstrating the preclinical efficacy of a new candidate vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the agent that causes coronavirus disease 2019 (COVID-19).
A study co-authored by Dr. Michael A. Lindsey, Executive Director of the McSilver Institute for Poverty Policy & Research at the Silver of Social Work at New York University, has found that transgender people who are denied access to mental health treatment experience a higher risk of substance abuse and attempted suicide.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Allan R Kornfeld, MD 2400 N Rockton Ave, Rockford, IL 61103-3655 Ph: (815) 971-5000 | Dr Allan R Kornfeld, MD 2400 N Rockton Ave, Rockford, IL 61103-3655 Ph: (815) 971-2000 |
News Archive
Simcere Pharmaceutical Group, a leading manufacturer and supplier of branded generic pharmaceuticals and manufacturer of the patented anti-cancer biotech product Endostar (also known as Endu) in China, announced today the successful completion of Endostar Phase IV clinical study at a conference in Beijing dedicated to this study.
Merck KGaA announced today that it has acquired Suzhou Taizhu Technology Development Co. Ltd. ("Taizhu"), a leading supplier of effect pigments located in Taicang near Shanghai, China. With total revenues of more than € 14 million in 2008 and 300 employees Taizhu is one of the biggest effect pigments companies in the Chinese market. The acquisition is of high strategic importance to the Merck pigments business.
Neurobiological Technologies, Inc. (Nasdaq: NTII) ("NTI") announced today that, on September 15, 2009, it received a letter from The Nasdaq Stock Market indicating that the bid price of NTI's common stock has closed below $1.00 per share for 30 consecutive business days.
Researchers in the United States and Germany have conducted a study demonstrating the preclinical efficacy of a new candidate vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the agent that causes coronavirus disease 2019 (COVID-19).
A study co-authored by Dr. Michael A. Lindsey, Executive Director of the McSilver Institute for Poverty Policy & Research at the Silver of Social Work at New York University, has found that transgender people who are denied access to mental health treatment experience a higher risk of substance abuse and attempted suicide.
› Verified 9 days ago
Mark J. Kellen, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 5875 E Riverside Blvd, Rockford, IL 61114 Phone: 815-398-9491 Fax: 815-381-7498 | |
Alan G Mowbray, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 2400 N Rockton Ave, Rockford, IL 61103 Phone: 815-971-4000 | |
John N. Edwards, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 6785 Weaver Rd, Suite D, Rockford, IL 61114 Phone: 815-633-8545 | |
Dr. Vishrut P. Naik, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 5875 E Riverside Blvd, Rockford, IL 61114 Phone: 815-398-9491 | |
Adam Soliman, DO Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 5875 E Riverside Blvd, Rockford, IL 61114 Phone: 815-398-9491 Fax: 815-381-7498 | |
Dr. William Stephen Minore, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1235 N Mulford Rd Ste 222, Rockford, IL 61107 Phone: 815-397-8400 Fax: 815-229-0050 | |
Stephen J. Martin, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 5875 E Riverside Blvd, Rockford, IL 61114 Phone: 815-398-9491 Fax: 815-381-7498 |